2026 意大利共识:免疫治疗时代III期非小细胞肺癌的多学科管理
梅斯医学
1天前
中·媒体
快速导读
意大利四大肿瘤协会联合发布新共识,更新免疫治疗时代III期非小细胞肺癌的管理框架。核心强调精准分期、分子分析及多学科协作决策,旨在为可切除及边缘可切除患者优化多模式治疗策略。
2026 意大利共识:免疫治疗时代III期非小细胞肺癌的多学科管理
分享
相关资料下载:
[AttachmentFileName(sort=1, fileName=Multidisciplinary Management of Stage III NSCLC in the Immunotherapy Era_ An Italian Delphi Consensus from AIOM, SICT, SIAPEC, and AIRO.pdf)]
GetToolGuiderByIdResponse(projectId=1, id=7df1c1c0056036c6, title=2026 意大利共识:免疫治疗时代III期非小细胞肺癌的多学科管理, enTitle=Multidisciplinary Management of Stage III NSCLC in the Immunotherapy Era: An Italian Delphi Consensus from AIOM, SICT, SIAPEC, and AIRO, guiderFrom=JTO Clin Res Rep , authorId=0, author=, summary=本文针对III期NSCLC的多学科管理提供了一个更新的框架,强调准确的分期、分子分析和协调的多学科决策,以优化多模式治疗策略。, cover=https://img.medsci.cn/20240613/1718257895701_5579292.png, journalId=0, articlesId=null, associationId=1673, associationName=意大利肿瘤医学协会, associationIntro=, copyright=0, guiderPublishedTime=Thu Sep 03 00:00:00 CST 2026, originalUrl=, linkOutUrl=, content=
, tagList=[TagDto(tagId=276, tagName=非小细胞肺癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100)], articleKeywordId=276, articleKeyword=非小细胞肺癌, articleKeywordNum=6, guiderKeywordId=276, guiderKeyword=非小细胞肺癌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=159, appHits=8, showAppHits=0, pcHits=16, showPcHits=151, likes=0, shares=2, comments=0, approvalStatus=1, publishedTime=Wed Nov 18 08:20:00 CST 2026, publishedTimeString=2026-09-03, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Tue Nov 17 10:14:37 CST 2026, updatedBy=8538692, updatedName=梅斯平台小助手, updatedTime=Tue Nov 17 13:54:15 CST 2026, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=上海, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=Multidisciplinary Management of Stage III NSCLC in the Immunotherapy Era_ An Italian Delphi Consensus from AIOM, SICT, SIAPEC, and AIRO.pdf)])
Multidisciplinary Management of Stage III NSCLC in the Immunotherapy Era_ An Italian Delphi Consensus from AIOM, SICT, SIAPEC, and AIRO.pdf
2026-09-03 意大利肿瘤医学协会 JTO Clin Res Rep 发表于上海
中文标题:本文针对III期NSCLC的多学科管理提供了一个更新的框架,强调准确的分期、分子分析和协调的多学科决策,以优化多模式治疗策略。
2026 意大利共识:免疫治疗时代III期非小细胞肺癌的多学科管理
英文标题:Multidisciplinary Management of Stage III NSCLC in the Immunotherapy Era: An Italian Delphi Consensus from AIOM, SICT, SIAPEC, and AIRO
简要介绍:III期非小细胞肺癌(NSCLC)是胸部肿瘤学中最具异质性和临床挑战性的病例之一。免疫疗法与多模式治疗策略的快速整合重塑了治疗算法,特别是对于可切除和边缘性可切除疾病。本文针对III期NSCLC的多学科管理提供了一个更新的框架,强调准确的分期、分子分析和协调的多学科决策,以优化多模式治疗策略。
分享
相关资料下载:
[AttachmentFileName(sort=1, fileName=Multidisciplinary Management of Stage III NSCLC in the Immunotherapy Era_ An Italian Delphi Consensus from AIOM, SICT, SIAPEC, and AIRO.pdf)]
GetToolGuiderByIdResponse(projectId=1, id=7df1c1c0056036c6, title=2026 意大利共识:免疫治疗时代III期非小细胞肺癌的多学科管理, enTitle=Multidisciplinary Management of Stage III NSCLC in the Immunotherapy Era: An Italian Delphi Consensus from AIOM, SICT, SIAPEC, and AIRO, guiderFrom=JTO Clin Res Rep , authorId=0, author=, summary=本文针对III期NSCLC的多学科管理提供了一个更新的框架,强调准确的分期、分子分析和协调的多学科决策,以优化多模式治疗策略。, cover=https://img.medsci.cn/20240613/1718257895701_5579292.png, journalId=0, articlesId=null, associationId=1673, associationName=意大利肿瘤医学协会, associationIntro=, copyright=0, guiderPublishedTime=Thu Sep 03 00:00:00 CST 2026, originalUrl=, linkOutUrl=, content=III期非小细胞肺癌(NSCLC)是胸部肿瘤学中最具异质性和临床挑战性的病例之一。免疫疗法与多模式治疗策略的快速整合重塑了治疗算法,特别是对于可切除和边缘性可切除疾病。本文针对III期NSCLC的多学科管理提供了一个更新的框架,强调准确的分期、分子分析和协调的多学科决策,以优化多模式治疗策略。
Multidisciplinary Management of Stage III NSCLC in the Immunotherapy Era_ An Italian Delphi Consensus from AIOM, SICT, SIAPEC, and AIRO.pdf